I think we're right to be somewhat concerned with the influence of money on the research process. That goes across the board; it's not special for cannabis. A lot of what we know about medicine today has been funded by pharmaceutical companies, and people have noticed the same problems you're talking about.
There are safeguards in place. I'm doing a study that's funded by Tilray. They're a licensed producer of cannabis. I don't get any money directly from Tilray. They don't impact my salary. My salary is paid by UBC.
I think that's typical for a lot of clinical trials. There are firewalls in place to maintain the integrity of the research and the integrity of the scientists who are conducting these trials. I think we need to be careful with that, but I don't think we can take that potential off the table, because we need so much research and the industry is one of the interests that's going to be able to fund that without dipping into, as you guys know, the already heavily taxed public coffers.
I don't think we could have a special case for cannabis whereby industry is not allowed to fund research. That's how so many of our medicines come to market. We do need to be careful about bias and ensure that the protections are in place.